Literature DB >> 2462354

Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.

S N Giri1, D M Hyde.   

Abstract

The effects of polyinosinic-polycytidylic acid (Poly I:C), an inducer of interferons, on bleomycin (Bleo)-induced lung fibrosis was studied in hamsters. Poly I:C (10 mg/kg intraperitoneally) was administered for two days and immediately before intratracheal instillation of bleomycin (7.5 U/kg) or an equivalent volume of saline and thereafter daily for 13 days. The lung hydroxyproline in control, Poly I:C, Bleo, and Bleo + Poly I:C groups averaged 791, 752, 1177, and 766 micrograms/lung. As compared to control, the prolyl hydroxylase activity in the Bleo group was increased by 83% whereas in Bleo + Poly I:C group, the activity was increased by 42%. Protein in the bronchoalveolar lavage supernatant in Poly I:C, Bleo and Bleo + Poly I:C groups were 72, 286, and 206% of the control, respectively. There was no difference in total leukocyte counts between Bleo + Poly I:C and Bleo groups, but the differential cell counts were changed. The numbers of neutrophils, monocytes, lymphocytes, and eosinophils were 50, 84, 91, and 10% of Bleo group, respectively. Morphometric estimates of the volume of parenchymal lesion within the lung showed that hamsters in Bleo + Poly I:C group had significantly less volume of lesion (1.0 cucm) than the Bleo group (1.6 cucm). In addition, the fibrotic lesions in Bleo + Poly I:C group were multifocal and primarily proximal acinar in location, had fewer extracellular fibers, neutrophils and monocytes. Poly I:C treatment ameliorated bleomycin-induced lung collagen accumulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462354      PMCID: PMC1880804     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  Analysis of bronchoalveolar lavage fluid from bleomycin-induced pulmonary fibrosis in hamsters.

Authors:  S N Giri; D M Hyde; J M Nakashima
Journal:  Toxicol Pathol       Date:  1986       Impact factor: 1.902

2.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis.

Authors:  L C Watters; T E King; M I Schwarz; J A Waldron; R E Stanford; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1986-01

3.  Phase-II study of recombinant alpha 2-interferon in advanced malignant melanoma.

Authors:  A Coates; M Rallings; P Hersey; C Swanson
Journal:  J Interferon Res       Date:  1986-02

4.  Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon.

Authors:  J Rosenbloom; G Feldman; B Freundlich; S A Jimenez
Journal:  Biochem Biophys Res Commun       Date:  1984-08-30       Impact factor: 3.575

5.  Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver.

Authors:  J James; K S Bosch; F M Zuyderhoudt; J M Houtkooper; J van Gool
Journal:  Histochemistry       Date:  1986

6.  Poly(ADP-ribose) synthetase activity during bleomycin-induced lung fibrosis in hamsters.

Authors:  M Z Hussain; S N Giri; R S Bhatnagar
Journal:  Exp Mol Pathol       Date:  1985-10       Impact factor: 3.362

7.  Induction of xanthine oxidase and depression of cytochrome P-450 by interferon inducers: genetic difference in the responses of mice.

Authors:  L Deloria; V Abbott; N Gooderham; G J Mannering
Journal:  Biochem Biophys Res Commun       Date:  1985-08-30       Impact factor: 3.575

8.  Protective effect of interferon inducers against hyperoxic pulmonary damage.

Authors:  Y Kikkawa; S Yano; L Skoza
Journal:  Lab Invest       Date:  1984-01       Impact factor: 5.662

9.  Bleomycin treatment of chick fibroblasts causes an increase of polysomal type I procollagen mRNAs. Reversal of the bleomycin effect by dexamethasone.

Authors:  K M Sterling; M J Harris; J J Mitchell; K R Cutroneo
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

10.  Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice.

Authors:  S N Giri; D M Hyde; B J Marafino
Journal:  Biochem Med Metab Biol       Date:  1986-10
View more
  5 in total

1.  TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis.

Authors:  Stephen K Frankel; Gregory P Cosgrove; Seung-Ick Cha; Carlyne D Cool; Murry W Wynes; Benjamin L Edelman; Kevin K Brown; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-04       Impact factor: 6.914

Review 2.  New strategies for treatment of pulmonary fibrosis.

Authors:  S H Phan
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

3.  A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling.

Authors:  Feng Fang; Kohtaro Ooka; Xiaoyong Sun; Ruchi Shah; Swati Bhattacharyya; Jun Wei; John Varga
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

Review 4.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Authors:  Antje Moeller; Kjetil Ask; David Warburton; Jack Gauldie; Martin Kolb
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

Review 5.  Cellular events in alveolitis and the evolution of pulmonary fibrosis.

Authors:  A Burkhardt; H Cottier
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.